COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,946 Articles (22,604 medRxiv, 8,342 bioRxiv)

Most recent first Previous |  Page 1550: Articles 15491-15500  | Next

EVIDENCE FOR BIOLOGICAL AGE ACCELERATION AND TELOMERE2 SHORTENING IN COVID-19 SURVIVORS
Mongelli, A., gaetano, c., gottardi zamperla, m., barbi, v., atlante, s., la rovere, m. t., bachetti, t., catalano, o., bussotti, m., della vecchia, l., nanni, s., farsetti, a., martelli, f.
10.1101/2021.04.23.21255973 — Posted: 2021-04-27 Discussion: Onsite
The Impact of Face Masks on Performance and Physiological Outcomes during Exercise: A Systematic Review and Meta-analysis
Shaw, K. A., Zello, G., Butcher, S., Ko, J. B., Bertrand, L. A., Chilibeck, P. D.
10.1101/2021.04.22.21255951 — Posted: 2021-04-27
A Generalizable Data Assembly Algorithm for Infectious Disease Outbreaks
Majumder, M. S., Rose, S.
10.1101/2021.04.21.21255862 — Posted: 2021-04-27
COVID-Nets: Deep CNN Architectures for Detecting COVID-19 Using Chest CT Scans
Alshazly, H., Linse, C., Abdalla, M., Barth, E., Martinetz, T.
10.1101/2021.04.19.21255763 — Posted: 2021-04-27
When can we stop wearing masks? Agent-based modeling to identify when vaccine coverage makes nonpharmaceutical interventions for reducing SARS-CoV-2 infections redundant in indoor gatherings
Farthing, T. S., Lanzas, C.
10.1101/2021.04.19.21255737 — Posted: 2021-04-27
Pharmacovigilance Analysis on Cerebrovascular Accidents and Coronavirus disease 2019 Vaccines
Aggarwal, P.
10.1101/2021.04.19.21255768 — Posted: 2021-04-27
Blood transcriptomes of anti-SARS-CoV2 antibody positive healthy individuals with prior asymptomatic versus clinical infection
Sfikakis, P. P., Verrou, K.-M., Tsitsilonis, O., Paraskevis, D., Kastritis, E., Lianidou, E., Moutsatsou, P., Terpos, E., Trougakos, I., Chini, V., Manoloukos, M., Pavlopoulos, G. A., Kollias, G., Ampatziadis-Michailidis, G., Hatzis, P., Dimopoulos, M. A.
10.1101/2021.04.19.21255748 — Posted: 2021-04-27
Association of ABO blood group with COVID-19 severity, acute phase reactants and mortality
Malik, J., Ishaq, U., Malik, A., Laique, T., Mehmood, A., Qureshi, A., Zaidi, S. M. J., Javaid, M., Rana, A. S.
10.1101/2021.04.19.21255738 — Posted: 2021-04-27
Antibody response after COVID-19 mRNA vaccination in relation to age, sex, and side effects
Naaber, P., Jurjenson, V., Adamson, A., Sepp, E., Tserel, L., Kisand, K., Peterson, P.
10.1101/2021.04.19.21255714 — Posted: 2021-04-27 Discussion: Onsite
Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia
Dodd, R. H., Pickles, K., Cvejic, E., Cornell, S., Isautier, J. M., Copp, T., Nickel, B., Bonner, C., Batcup, C., Muscat, D. M., Ayre, J., McCaffery, K. J.
10.1101/2021.04.19.21255709 — Posted: 2021-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).